General Information of the Compound
| Compound ID |
CP0393105
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-Chloro-2,3-dihydro-indole-1-carboxylic acid pyridin-3-ylamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
5-Chloro-1-(3-pyridylcarbamoyl)indoline
5-Chloro-2,3-dihydro-indole-1-carboxylic acid pyridin-3-ylamide
5-chloro-N-(pyridin-3-yl)indoline-1-carboxamide
BDBM50321877
BYXYRVSXGVLRKM-UHFFFAOYSA-N
CHEMBL290395
N-(3-Pyridinyl)-5-chloro-2,3-dihydro-1H-indole-1-carboxamide
SCHEMBL8527508
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C14H12ClN3O
|
||||||||||||||||||
| Molecular Weight |
273.723
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc2N(CCc2c1)C(=O)Nc1cccnc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C14H12ClN3O/c15-11-3-4-13-10(8-11)5-7-18(13)14(19)17-12-2-1-6-16-9-12/h1-4,6,8-9H,5,7H2,(H,17,19)
Show/Hide
|
||||||||||||||||||
| InChIKey |
BYXYRVSXGVLRKM-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Clinical Information about the Compound